Fisher Scientific Utilizes Signosis' Stable Cell Lines for High-Throughput Screening Assay Kit
Fisher Scientific has leveraged Signosis' state-of-the-art product lines, including the NFkB Luciferase Reporter NIH 3T3 Stable Cell Line...
Toll Free 1-877-266-8388 Tel: 1-408-747-0771 Fax: 1-408-470-7719
Fisher Scientific Utilizes Signosis' Stable Cell Lines for High-Throughput Screening Assay Kit
Pfizer's TicoVacâ„¢ achieves FDA Priority Review with the help of Signosis' Rat Inflammation ELISA
Johnson & Johnson Leverages Signosis' Stable Cell Lines for U.S. FDA EGFR Drug Development
Signosis' Luciferase Reporter Cell Lines and Johnson & Johnson's mRNA COVID-19 Vaccine Development
Signosis and Stratech Join Forces to Develop Advanced Tools for Studying Chemokines and Inflammation
Stanford Medicine Advances Molecular Biology with TF Activation Profiling Plate Array
Signosis Empowers National Institute of Health's Study on Identifying Functional Variants at Disease
Harvard Medicine's Study on TF Programming Landscape in hPSCs Utilizes Signosis' Comprehensive Array
Genentech's Study on the Peroxisomal Targeting Signal in Firefly Luciferase Reveals New Insights
Genentech Successfully Develops Monoclonal Antibody Production Using Signosis' Luciferase Line
What is the role of transcription factors in tumorigenesis and cancer treatment?
How do transfected stable cell lines advance biomedical research?